ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Opinion

Poison pill the wrong medicine when shady companies come knocking

Regulators must carefully assess threat posed by Asia Development Capital

| Japan
Tokyo Stock Exchange should focus on potential harm not only to shareholders of the target company but to acquirer's remaining general shareholders as well.   © Reuters

Stephen Givens is a corporate lawyer based in Tokyo.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more